Kiyotaka Akabori

Title: Kiyotaka Akabori: Innovator in Neutron Capture Therapy

Introduction

Kiyotaka Akabori is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of medical technology, particularly in neutron capture therapy. With a total of 2 patents, his work focuses on improving cancer treatment methods.

Latest Patents

Akabori's latest patents include a neutron capture therapy system and a gamma ray detector for neutron capture therapy. The neutron capture therapy system comprises a neutron ray generating unit, an irradiated body placing unit for patients, and a gamma ray detecting unit that identifies gamma rays emitted from the patient. The gamma ray detecting unit features an emission part that emits light or electrons when gamma rays are incident, an amplification part that enhances the emitted light or electrons, and two neutron ray shielding parts designed to optimize detection accuracy.

The second patent, a neutron ray detecting system, involves a method for setting the neutron ray detecting system. This system allows for the acquisition of neutron ray wave height distribution and gamma ray wave height distribution, enabling the determination of how much gamma rays are detected as noise. By using a filter that cuts neutron rays, the relationship between the determination threshold value and detection accuracy can be accurately established. This innovation allows for the adjustment of the determination threshold value in accordance with the required detection accuracy.

Career Highlights

Throughout his career, Kiyotaka Akabori has worked with prominent organizations such as Sumitomo Heavy Industries, Ltd. and Kyoto University. His experience in these institutions has contributed to his expertise in the field of neutron capture therapy.

Collaborations

One of his notable collaborators is Hiroki Tanaka, with whom he has worked on various projects related to his patents.

Conclusion

Kiyotaka Akabori's contributions to neutron capture therapy demonstrate his commitment to advancing medical technology. His innovative patents reflect his dedication to improving cancer treatment methods and enhancing detection accuracy.